本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

The Oncology Institute

2.61
-0.0400-1.51%
盘后2.60-0.0100-0.38%19:31 EDT
成交量:132.64万
成交额:318.00万
市值:1.98亿
市盈率:-3.70
高:2.64
开:2.57
低:2.22
收:2.65
数据加载中...
2022/03/10

重要事件披露

8-K - Current report
2022/03/07

重要事件披露

8-K - Current report
2022/02/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2022/02/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/01/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/01/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/17

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/12/14

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/12/14

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2021/12/09

重要事件披露

8-K - Current report
2021/11/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/24

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership